Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
[This corrects the article DOI: 10.18632/oncotarget.13531.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824877 | PMC |
| http://dx.doi.org/10.18632/oncotarget.27296 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Publisher Correction to: RETRACTED ARTICLE: Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN.
Cell Oncol (Dordr)
December 2023
Department of Neurosurgery, Henan Province People's Hospital, Zhengzhou University, No. 7, Weiwu Road, Zhengzhou, 450003, Henan Province, People's Republic of China.
Correction to: Silenced lncRNA DDX11-AS1 or up-regulated microRNA-34a-3p inhibits malignant phenotypes of hepatocellular carcinoma cells via suppression of TRAF5.
Cancer Cell Int
December 2021
Department of Infectious Diseases, Henan Key Laboratory for Liver Disease, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, No. 7 Weiwu Road, Zhengzhou, 450003, Henan, China.
Correction to: Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells.
Stem Cell Res Ther
July 2020
Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism, The Second Affiliated Hospital of Harbin Medical University, 148 BaojianRoad, Harbin, 150086, P.R. China.
An amendment to this paper has been published and can be accessed via the original article.
View Article and Find Full Text PDFCorrection: MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma.
Oncotarget
October 2019
Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
[This corrects the article DOI: 10.18632/oncotarget.13531.
View Article and Find Full Text PDF